Head-to-head · Cost-Efficiency Index
CoreAge Rx vs myRocky
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxmyRocky
Cost-first shoppers who want the real FDA-approved branded pens (not a compounded copy), for shoppers willing to pay branded-drug prices.
Visit myRockyThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 38. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. myRocky still earns a C — Cost-first shoppers who want the real FDA-approved branded pens (not a compounded copy), for shoppers willing to pay branded-drug prices.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | myRocky |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 38/100 |
| Semaglutide / mo | $99/mo | $1,409/mo (brand Ozempic, plus a separate fee) |
| Tirzepatide / mo | $149/mo | $1,509/mo (brand Mounjaro, plus a separate fee) |
| Semaglutide / yr (modeled) | $1,188 | $16,908 |
| Tirzepatide / yr (modeled) | $1,788 | $18,108 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #1 | #535 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
myRocky
38/100Where the value is
- Sells only genuine FDA-approved branded medications (Ozempic, Wegovy, Mounjaro) rather than compounded copies — a real differentiator from most of the other sites in this batch
- LegitScript-approved pharmacy, publishing the number #308582 beside that claim (we could not resolve it as a LegitScript seal ID in August 2026; it may be a pharmacy license number, which that registry would not serve)
- Explicit 42-state coverage list published on a dedicated service-coverage page, with 8 more states named as 'coming soon' — more specific than most peers' vague language
The tradeoffs
- Pricing is split across a $99 consult, a separate $99/month program fee, and the drug cost itself — a shopper reading only '$99/month' would badly underestimate the real all-in cost
- None of the three drug-specific pages (Ozempic $1,409, Wegovy $1,869, Mounjaro $1,509) discloses whether that figure is a one-month or multi-month supply
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.